Cargando…
Biomaterial-Mediated Genetic Reprogramming of Merkel Cell Carcinoma and Melanoma Leads to Targeted Cancer Cell Killing In Vitro and In Vivo
[Image: see text] Tumor immunotherapy is a promising anticancer strategy; however, tumor cells may employ resistance mechanisms, including downregulation of major histocompatibility complex (MHC) molecules to avoid immune recognition. Here, we investigate reprogramming nanoparticles (NPs) that deliv...
Autores principales: | Luly, Kathryn M, Green, Jordan J, Sunshine, Joel C, Tzeng, Stephany Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646862/ https://www.ncbi.nlm.nih.gov/pubmed/37797944 http://dx.doi.org/10.1021/acsbiomaterials.3c00885 |
Ejemplares similares
-
Are there Multiple Cells of Origin of Merkel Cell Carcinoma?
por: Sunshine, J. C., et al.
Publicado: (2018) -
Poly(β-Amino Ester)-Nanoparticle Mediated Transfection of Retinal Pigment Epithelial Cells In Vitro and In Vivo
por: Sunshine, Joel C., et al.
Publicado: (2012) -
Molecular Profiling of Merkel Cell Polyomavirus-Associated Merkel Cell Carcinoma and Cutaneous Melanoma
por: Mokánszki, Attila, et al.
Publicado: (2021) -
An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo
por: Cheung, Melissa C, et al.
Publicado: (2010) -
Polymeric nanoparticle‐based delivery of TRAIL DNA for cancer‐specific killing
por: Tzeng, Stephany Y., et al.
Publicado: (2016)